{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:26:36Z","timestamp":1792290396361,"version":"4.4.0"},"reference-count":103,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2014.00470","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T14:43:55Z","timestamp":1420469035000},"source":"Crossref","is-referenced-by-count":45,"title":["Encapsulating peritoneal sclerosis\u00e2\u20ac\u201da rare but devastating peritoneal disease"],"prefix":"10.3389","volume":"5","author":[{"given":"Zia","family":"Moinuddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Van Dellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titus","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Herrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,1,5]]},"reference":[{"key":"B1","first-page":"262","article-title":"Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients","volume":"6","author":"Aguilera","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1053\/j.ajkd.2006.11.040","article-title":"Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients","volume":"49","author":"Alscher","year":"2007","journal-title":"Am. J. Kidney Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J. Am. Soc. Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000191214","article-title":"Encapsulating peritoneal sclerosis: clinical significance and implications","volume":"111","author":"Augustine","year":"2009","journal-title":"Nephron. Clin. Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/ndt\/gfp008","article-title":"The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis","volume":"24","author":"Balasubramaniam","year":"2009","journal-title":"Nephrol. Dial. Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"912595","DOI":"10.1155\/2012\/912595","article-title":"Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis","volume":"2012","author":"Baroni","year":"2012","journal-title":"Mediators Inflamm"},{"key":"B7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/089686080802800106","article-title":"Peritoneal and systemic inflammation: the benefits of using biocompatible peritoneal dialysis fluids","volume":"28","author":"Boulanger","year":"2008","journal-title":"Perit. Dial. Int"},{"key":"B8","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1177\/089686080902902S42","article-title":"Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis?","volume":"29","author":"Bozkurt","year":"2009","journal-title":"Perit. Dial. Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e48647","DOI":"10.1371\/journal.pone.0048647","article-title":"Histological criteria for encapsulating peritoneal sclerosis\u00e2\u20ac\u201da standardized approach","volume":"7","author":"Braun","year":"2012","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"c88","DOI":"10.1159\/000228540","article-title":"Fibrogenic growth factors in encapsulating peritoneal sclerosis","volume":"113","author":"Braun","year":"2009","journal-title":"Nephron. Clin. Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.2215\/CJN.01260209","article-title":"Encapsulating peritoneal sclerosis in the new millennium: a national cohort study","volume":"4","author":"Brown","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2013.00098","article-title":"Anthropometrics identify wasting in patients undergoing surgery for encapsulating peritoneal sclerosis","author":"Campbell","year":"2014","journal-title":"Perit. Dial. Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/ndt\/12.4.821","article-title":"Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae","volume":"12","author":"Chew","year":"1997","journal-title":"Nephrol. Dial. Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11255-010-9744-5","article-title":"Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data","volume":"43","author":"Cornelis","year":"2011","journal-title":"Int. Urol. Nephrol"},{"key":"B15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/089686080802800314","article-title":"Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis","volume":"28","author":"De Freitas","year":"2007","journal-title":"Perit. Dial. Int"},{"key":"B16","first-page":"32","article-title":"Clinical experience with tamoxifen in peritoneal fibrosing syndromes","volume":"19","author":"Del Peso","year":"2003","journal-title":"Adv. Perit. Dial"},{"key":"B17","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1681\/ASN.V1482109","article-title":"Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane","volume":"14","author":"De Vriese","year":"2003","journal-title":"J. Am. Soc. Nephrol"},{"key":"B17a","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/ndt\/gfl271","article-title":"Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia","volume":"21","author":"De Vriese","year":"2006","journal-title":"Nephrol. Dial. Transplant"},{"key":"B18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/089686080702700603","article-title":"Posttransplant encapsulating peritoneal sclerosis: a worrying new trend?","volume":"27","author":"Fieren","year":"2007","journal-title":"Perit. Dial. Int"},{"key":"B19","doi-asserted-by":"crossref","first-page":"A113","DOI":"10.1016\/0002-9343(84)91017-9","article-title":"Peritoneal dialysis complicated by fungal peritonitis and peritoneal fibrosis","volume":"76","author":"Flanigan","year":"1984","journal-title":"Am. J. Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1681\/ASN.2006121417","article-title":"Peritoneal changes after exposure to sterile solutions by catheter","volume":"18","author":"Flessner","year":"2007","journal-title":"J. Am. Soc. Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/archinte.1980.00330200077024","article-title":"Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients","volume":"140","author":"Gandhi","year":"1980","journal-title":"Arch. Intern. Med"},{"key":"B22","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1177\/089686080502503S28","article-title":"Sclerosing peritonitis: a nosological entity","volume":"25","author":"Garosi","year":"2005","journal-title":"Perit. Dial. Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/ndt\/gfq533","article-title":"Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanning","volume":"26","author":"Goodlad","year":"2011","journal-title":"Nephrol. Dial. Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0002-9440(10)61190-X","article-title":"Experimental manipulation of transforming growth factor-beta isoforms significantly affects adhesion formation in a murine surgical model","volume":"167","author":"Gorvy","year":"2005","journal-title":"Am. J. Pathol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/089686080902900304","article-title":"Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanisms of action and update of clinical experiences","volume":"29","author":"Guest","year":"2009","journal-title":"Perit. Dial. Int"},{"key":"B26","first-page":"500","article-title":"Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment","volume":"69","author":"Habib","year":"2011","journal-title":"Neth. J. Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/ndt\/gfl566","article-title":"The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis\u00e2\u20ac\u201ca multicentre study in Japan","volume":"22","author":"Hirahara","year":"2007","journal-title":"Nephrol. Dial. Transplant"},{"key":"B28","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1177\/089686080502504S08","article-title":"Experimental animal models of encapsulating peritoneal sclerosis","volume":"25","author":"Hoff","year":"2005","journal-title":"Perit. Dial. Int. J. Int. Soc. Perit. Dial"},{"key":"B29","first-page":"24","article-title":"The role of fibrinolysis in adhesion formation","volume":"163","author":"Holmdahl","year":"1997","journal-title":"Eur. J. Surg. Suppl"},{"key":"B30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/msy.2001.113039","article-title":"Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment","volume":"129","author":"Holmdahl","year":"2001","journal-title":"Surgery"},{"key":"B31","first-page":"169","article-title":"Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients","volume":"19","author":"Honda","year":"2003","journal-title":"Adv. Perit. Dial. Conf. Perit. Dial"},{"key":"B32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000188837","article-title":"Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure","volume":"72","author":"Honda","year":"1996","journal-title":"Nephron"},{"key":"B33","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1177\/089686080502504S04","article-title":"Pathology of encapsulating peritoneal sclerosis","volume":"25","author":"Honda","year":"2005","journal-title":"Perit. Dial. Int"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1523-1755.2004.00599.x","article-title":"Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models","volume":"65","author":"Io","year":"2004","journal-title":"Kidney Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00428-003-0963-3","article-title":"Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis","volume":"444","author":"Jimenez-Heffernan","year":"2004","journal-title":"Virchows Arch"},{"key":"B36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/039139889201500203","article-title":"Biocompatibility of peritoneal dialysis fluids","volume":"15","author":"Jorres","year":"1992","journal-title":"Int. J. Artif. Organs"},{"key":"B37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3346\/jkms.2013.28.4.620","article-title":"A case of fulminant sclerosing peritonitis presented like acute culture-negative peritonitis and successfully treated with corticosteroid therapy","volume":"28","author":"Jung","year":"2013","journal-title":"J. Korean Med. Sci"},{"key":"B38","first-page":"187","article-title":"Immunosuppression in sclerosing peritonitis","volume":"9","author":"Junor","year":"1993","journal-title":"Adv. Perit. Dial"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest"},{"key":"B40","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1177\/089686080002004S04","article-title":"Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis","volume":"20","author":"Kawaguchi","year":"2000","journal-title":"Perit. Dial. Int"},{"key":"B41","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1177\/089686080502504S12","article-title":"Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures","volume":"25","author":"Kawaguchi","year":"2005","journal-title":"Perit. Dial. Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000336934","article-title":"Surgical and medical treatments of encapsulation peritoneal sclerosis","volume":"177","author":"Kawanishi","year":"2012","journal-title":"Contrib. Nephrol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1053\/j.ajkd.2004.06.020","article-title":"Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study","volume":"44","author":"Kawanishi","year":"2004","journal-title":"Am. J. Kidney Dis"},{"key":"B44","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1177\/089686080502504S03","article-title":"Epidemiology of encapsulating peritoneal sclerosis in Japan","volume":"25","author":"Kawanishi","year":"2005","journal-title":"Perit. Dial. Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1046\/j.1523-1755.2002.00668.x","article-title":"Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity","volume":"62","author":"Khanna","year":"2002","journal-title":"Kidney Int"},{"key":"B46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/089686080702700413","article-title":"Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients","volume":"27","author":"Kolesnyk","year":"2007","journal-title":"Perit. Dial. Int"},{"key":"B47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/ndt\/gfq362","article-title":"Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study","volume":"26","author":"Korte","year":"2011b","journal-title":"Nephrol. Dial. Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrneph.2011.93","article-title":"Encapsulating peritoneal sclerosis: the state of affairs","volume":"7","author":"Korte","year":"2011a","journal-title":"Nat. Rev. Nephrol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/ndt\/16.6.1304","article-title":"Corticosteroid therapy in encapsulating peritoneal sclerosis","volume":"16","author":"Kuriyama","year":"2001","journal-title":"Nephrol. Dial. Transplant"},{"key":"B50","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ndt\/gfg141","article-title":"Pentoxifylline modulates intracellular signalling of TGF-\u00ce\u00b2 in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosis","volume":"18","author":"Hung","year":"2003","journal-title":"Nephrol. Dial. Transplant"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1053\/j.ajkd.2007.07.036","article-title":"Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy","volume":"51","author":"Lafrance","year":"2008","journal-title":"Am. J. Kidney Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/ndt\/gfs159","article-title":"Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany","volume":"28","author":"Latus","year":"2013","journal-title":"Nephrol. Dial. Transplant"},{"key":"B53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000013397","article-title":"Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence","volume":"6","author":"Lin","year":"1998","journal-title":"Am. J. Nephrol"},{"key":"B54","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/089686080902900507","article-title":"Prolonged peritoneal gene expression using a helper-dependent adenovirus","volume":"29","author":"Liu","year":"2009","journal-title":"Perit. Dial. Int"},{"key":"B55","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1177\/089686080902902S43","article-title":"Encapsulating peritoneal sclerosis\u00e2\u20ac\u201cmedical and surgical treatment","volume":"29","author":"Lo","year":"2009","journal-title":"Perit. Dial. Int"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1681\/ASN.2010111197","article-title":"Blocking TGF-\u00ce\u00b21 protects the peritoneal membrane from dialysate-induced damage","volume":"22","author":"Loureiro","year":"2011","journal-title":"J. Am. Soc. Nephrol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"263285","DOI":"10.1155\/2013\/263285","article-title":"Are the mesothelial-to-mesenchymal transition, sclerotic peritonitis syndromes, and encapsulating peritoneal sclerosis part of the same process?","volume":"2013","author":"Loureiro","year":"2013b","journal-title":"Int. J. Nephrol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e61165","DOI":"10.1371\/journal.pone.0061165","article-title":"Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis","volume":"23","author":"Loureiro","year":"2013a","journal-title":"PLoS ONE"},{"key":"B59","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1046\/j.1523-1755.2002.00143.x","article-title":"Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells","volume":"61","author":"Mandl-Weber","year":"2002","journal-title":"Kidney Int"},{"key":"B60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/089686080302300604","article-title":"Basic mechanisms and clinical implications of peritoneal fibrosis","volume":"23","author":"Margetts","year":"2003","journal-title":"Perit. Dial. Int"},{"key":"B61","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2004060436","article-title":"Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum","volume":"16","author":"Margetts","year":"2005","journal-title":"J. Am. Soc. Nephrol"},{"key":"B62","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1177\/089686080802803s37","article-title":"Encapsulating peritoneal sclerosis in Japan","volume":"28","author":"Maruyama","year":"2008","journal-title":"Perit. Dial. Int"},{"key":"B63","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1526-0968.2003.00087.x","article-title":"Ascites from patients with encapsulating peritoneal sclerosis augments NIH\/3T3 fibroblast proliferation","volume":"7","author":"Masunaga","year":"2003","journal-title":"Ther. Apher. Dial"},{"key":"B64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Perit. Dial. Int"},{"key":"B65","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0272-6386(97)90064-0","article-title":"A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone","volume":"30","author":"Mori","year":"1997","journal-title":"Am. J. Kidney Dis"},{"key":"B66","first-page":"149","article-title":"Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis","volume":"18","author":"Moriishi","year":"2002","journal-title":"Adv. Perit. Dial"},{"key":"B67","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1681\/ASN.V132480","article-title":"Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products","volume":"13","author":"Mortier","year":"2002","journal-title":"J. Am. Soc. Nephrol"},{"key":"B68","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1177\/089686080502504S05","article-title":"Encapsulating peritoneal sclerosis\u00e2\u20ac\u201da clinician's approach to diagnosis and medical treatment","volume":"4","author":"Nakamoto","year":"2005","journal-title":"Perit. Dial. Int. Suppl"},{"key":"B69","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ki.1997.22","article-title":"Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD","volume":"51","author":"Nakayama","year":"1997","journal-title":"Kidney Int"},{"key":"B70","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/089686080802805S05","article-title":"Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment","volume":"28","author":"Park","year":"2008","journal-title":"Perit. Dial. Int"},{"key":"B71","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrneph.2012.144","article-title":"Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions","volume":"8","author":"Pletinck","year":"2012","journal-title":"Nat. Rev. Nephrol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1046\/j.1523-1755.2001.07801.x","article-title":"Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties","volume":"78","author":"Plum","year":"2001","journal-title":"Kidney Int. Suppl"},{"key":"B73","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1177\/089686080102103S10","article-title":"Diagnosis and management of encapsulating peritoneal sclerosis","volume":"21","author":"Pollock","year":"2001","journal-title":"Perit. Dial. Int"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/ndt\/17.12.2278","article-title":"Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis","volume":"17","author":"Rajani","year":"2002","journal-title":"Nephrol. Dial. Transplant"},{"key":"B75","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ndt\/13.1.154","article-title":"Sclerosing peritonitis: the experience in Australia","volume":"13","author":"Rigby","year":"1998","journal-title":"Nephrol. Dial. Transplant"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1093\/ndt\/gfm323","article-title":"Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats","volume":"22","author":"Ro","year":"2007","journal-title":"Nephrol. Dial. Transplant"},{"key":"B77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1523-1755.1998.00955.x","article-title":"PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1","volume":"54","author":"Rougier","year":"1998","journal-title":"Kidney Int"},{"key":"B78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3747\/pdi.2009.00022","article-title":"Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study","volume":"30","author":"Sampimon","year":"2010","journal-title":"Perit. Dial. Int"},{"key":"B79","doi-asserted-by":"publisher","first-page":"ii2","DOI":"10.1093\/ndt\/gfl183","article-title":"Epithelial-to-mesenchymal transition of the mesothelial cell\u00e2\u20ac\u201cits role in the response of the peritoneum to dialysis","volume":"21","author":"Selgas","year":"2006","journal-title":"Nephrol. Dial. Transplant"},{"key":"B80","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1744-9987.2007.00538.x","article-title":"Comparison between the pathology of encapsulating sclerosis and simple sclerosis of the peritoneal membrane in chronic peritoneal dialysis","volume":"12","author":"Sherif","year":"2008","journal-title":"Ther. Apher. Dial"},{"key":"B81","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1042\/BST0300126","article-title":"Role of plasminogen activators in peritoneal adhesion formation","volume":"30","author":"Sulaiman","year":"2002","journal-title":"Biochem. Soc. Trans"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1111\/j.1523-1755.2005.00701.x","article-title":"Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure","volume":"68","author":"Summers","year":"2005","journal-title":"Kidney Int"},{"key":"B83","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/089686080802805S04","article-title":"How can genetic advances impact on experimental models of encapsulating peritoneal sclerosis?","volume":"28","author":"Summers","year":"2008","journal-title":"Perit. Dial. Int"},{"key":"B84","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0272-6386(96)90523-5","article-title":"Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients","volume":"27","author":"Tomura","year":"1996","journal-title":"Am. J. Kidney Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000112475","article-title":"Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat","volume":"25","author":"Van Westrhenen","year":"2007","journal-title":"Blood Purif"},{"key":"B87","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686080902900508","article-title":"Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study","volume":"29","author":"Vlijm","year":"2009","journal-title":"Perit. Dial. Int"},{"key":"B88","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/oxfordjournals.ndt.a027512","article-title":"Cytotoxicity of peritoneal dialysis fluid\u00e2\u20ac\u201dis it related to glucose breakdown products?","volume":"11","author":"Wieslander","year":"1996","journal-title":"Nephrol. Dial. Transplant"},{"key":"B89","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1046\/j.1523-1755.2003.08805.x","article-title":"The natural course of peritoneal membrane biology during peritoneal dialysis","volume":"88","author":"Williams","year":"2003","journal-title":"Kidney Int. Suppl"},{"key":"B90","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J. Am. Soc. Nephrol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0022-4804(92)90280-D","article-title":"Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum","volume":"52","author":"Williams","year":"1992","journal-title":"J. Surg. Res"},{"key":"B92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/089686080502500312","article-title":"Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone","volume":"25","author":"Wong","year":"2005","journal-title":"Perit. Dial. Int"},{"key":"B93","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3747\/pdi.2010.00078","article-title":"Initial observations using a novel \u00e2\u20ac\u0153cine\u00e2\u20ac\u009d magnetic resonance imaging technique to detect changes in abdominal motion caused by encapsulating peritoneal sclerosis","volume":"31","author":"Wright","year":"2011","journal-title":"Perit. Dial. Int"},{"key":"B94","first-page":"354","article-title":"Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure","volume":"42","author":"Yamada","year":"1994","journal-title":"Clin. Nephrol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10157-005-0349-8","article-title":"Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment","volume":"9","author":"Yamamoto","year":"2005","journal-title":"Clin. Exp. Nephrol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3747\/pdi.2008.00273","article-title":"The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis","volume":"30","author":"Yamamoto","year":"2010","journal-title":"Perit. Dial. Int"},{"key":"B97","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to- mesenchymal transition of mesothelial cells","volume":"348","author":"Yanez-Mo","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1046\/j.1523-1755.2003.00861.x","article-title":"Myofibroblastic conversion of mesothelial cells","volume":"63","author":"Yang","year":"2003","journal-title":"Kidney Int"},{"key":"B99","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1681\/ASN.2008040424","article-title":"HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium","volume":"20","author":"Yu","year":"2009","journal-title":"J. Am. Soc. Nephrol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3892\/etm.2013.1281","article-title":"Changes in expression of four molecular marker proteins and one microRNA in mesothelial cells of the peritoneal dialysate effluent fluid of peritoneal dialysis patients","volume":"6","author":"Zhang","year":"2013","journal-title":"Exp. Ther. Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajpath.2013.05.019","article-title":"miR-30a negatively regulates TGF-\u00ce\u00b21-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1","volume":"183","author":"Zhou","year":"2013","journal-title":"Am. J. Pathol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1067\/mlc.2001.112235","article-title":"Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up","volume":"137","author":"Zweers","year":"2001","journal-title":"J. Lab. Clin. Med"}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T23:55:35Z","timestamp":1650930935000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphys.2014.00470\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,5]]},"references-count":103,"URL":"https:\/\/doi.org\/10.3389\/fphys.2014.00470","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,5]]}}}